- Home
- XHG vs ICUCW Comparison
XHG vs ICUCW Comparison
Compare XHG & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XHG
- ICUCW
- Stock Information
- Founded
- XHG 2012
- ICUCW N/A
- Country
- XHG China
- ICUCW United States
- Employees
- XHG N/A
- ICUCW 19
- Industry
- XHG
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- XHG
- ICUCW Health Care
- Exchange
- XHG NYSE
- ICUCW Nasdaq
- Market Cap
- XHG 65.5M
- ICUCW N/A
- IPO Year
- XHG 2019
- ICUCW 2021
- Fundamental
- Price
- XHG $1.40
- ICUCW $0.03
- Analyst Decision
- XHG
- ICUCW
- Analyst Count
- XHG 0
- ICUCW 0
- Target Price
- XHG N/A
- ICUCW N/A
- AVG Volume (30 Days)
- XHG 121.9K
- ICUCW N/A
- Earning Date
- XHG 07-18-2025
- ICUCW N/A
- Dividend Yield
- XHG N/A
- ICUCW N/A
- EPS Growth
- XHG N/A
- ICUCW N/A
- EPS
- XHG N/A
- ICUCW N/A
- Revenue
- XHG $41,110,414.00
- ICUCW N/A
- Revenue This Year
- XHG N/A
- ICUCW N/A
- Revenue Next Year
- XHG N/A
- ICUCW N/A
- P/E Ratio
- XHG N/A
- ICUCW N/A
- Revenue Growth
- XHG N/A
- ICUCW N/A
- 52 Week Low
- XHG $1.16
- ICUCW N/A
- 52 Week High
- XHG $1,200.00
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- XHG 37.77
- ICUCW N/A
- Support Level
- XHG $1.26
- ICUCW N/A
- Resistance Level
- XHG $1.37
- ICUCW N/A
- Average True Range (ATR)
- XHG 0.12
- ICUCW 0.00
- MACD
- XHG 0.08
- ICUCW 0.00
- Stochastic Oscillator
- XHG 42.02
- ICUCW 0.00
About XHG XCHANGE TEC.INC SPON ADS EACH REP 600000 SHS(POST SPLIT)
XChange Tec Inc, through its subsidiaries operates in insurance agency and insurance technology business. The company specialized in distributing automobile insurance policies at the earlier stage of business and subsequently expanded insurance product portfolio to include other types of insurance including life, health, group accident and other property related insurances. A maximum of the insurance purchased through platform and agency services is of automobile insurance.
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.